Arcus Biosciences (RCUS) News Today → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free RCUS Stock Alerts $14.84 0.00 (0.00%) (As of 04/18/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineEli Lilly subsidiary ends lucrative collaboration with Durham biotechbizjournals.com - April 18 at 7:57 AMPrecision BioSciences: Strategic Independence and Promising Gene Editing Pipeline Fuel Buy Ratingmarkets.businessinsider.com - April 18 at 1:45 AMBuy Rating Affirmed for Precision BioSciences Amid Strong Gene Editing Prospects and Upcoming Milestonesmarkets.businessinsider.com - April 17 at 8:44 PMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - April 9 at 4:35 PMVanguard Group Inc. Acquires 61,040 Shares of Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - April 6 at 4:15 AMArcus Biosciences (NYSE:RCUS) Shares Down 2.8% marketbeat.com - April 3 at 1:57 PMInvestors bid Arcus Biosciences (NYSE:RCUS) up US$219m despite increasing losses YoY, taking five-year CAGR to 8.1%finance.yahoo.com - April 1 at 9:26 AMInsider Selling: Arcus Biosciences, Inc. (NYSE:RCUS) COO Sells 11,551 Shares of Stockinsidertrades.com - March 30 at 7:35 AMInsider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)finance.yahoo.com - March 29 at 7:52 PMArcus Biosciences, Inc. (NYSE:RCUS) COO Jennifer Jarrett Sells 11,551 Sharesmarketbeat.com - March 29 at 6:40 PMXilio and Gilead partner up for IL-12 therapeutic developmentmsn.com - March 29 at 2:09 AMArcus Biosciences (NYSE:RCUS) Trading Up 7.6%marketbeat.com - March 27 at 3:24 PMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - March 26 at 4:35 PMNavigating 5 Analyst Ratings For Arcus Biosciencesmarkets.businessinsider.com - March 25 at 4:20 PMTruist Financial Reiterates Buy Rating for Arcus Biosciences (NYSE:RCUS)marketbeat.com - March 25 at 1:11 PMArcus Biosciences COO sells over $240k in company stockinvesting.com - March 22 at 8:58 PMInsider Selling: Arcus Biosciences, Inc. (NYSE:RCUS) COO Sells 13,449 Shares of Stockinsidertrades.com - March 21 at 9:59 AMInsider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)finance.yahoo.com - March 20 at 10:12 PMArcus Biosciences (NYSE:RCUS) Shares Down 5.6% marketbeat.com - March 18 at 12:44 PMTraders Purchase Large Volume of Arcus Biosciences Call Options (NYSE:RCUS)marketbeat.com - March 13 at 11:20 AMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - March 11 at 4:35 PMArcus Biosciences (NYSE:RCUS) Trading 6.6% Higher marketbeat.com - March 11 at 3:17 PMTrexquant Investment LP Purchases Shares of 78,637 Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - March 5 at 7:52 AMArcus Biosciences, Inc. (NYSE:RCUS) Receives Consensus Recommendation of "Moderate Buy" from Analystsmarketbeat.com - March 2 at 1:59 AMInsider Sell: COO Jennifer Jarrett Sells 58,625 Shares of Arcus Biosciences Inc (RCUS)finance.yahoo.com - February 29 at 3:28 AMArcus Biosciences to Participate in Two Upcoming Investor Conferencesbusinesswire.com - February 28 at 4:05 PMFmr LLC Has $85.80 Million Holdings in Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - February 28 at 5:28 AMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - February 27 at 4:35 PM38,224 Shares in Arcus Biosciences, Inc. (NYSE:RCUS) Acquired by Dark Forest Capital Management LPmarketbeat.com - February 27 at 6:20 AMEvaluating Arcus Biosciences’ Casdatifan Potential and Strategic Position in RCC Treatment Landscapemarkets.businessinsider.com - February 26 at 8:15 AMArcus Biosciences, Inc. (NYSE:RCUS) to Post FY2028 Earnings of $1.87 Per Share, Wedbush Forecastsmarketbeat.com - February 23 at 8:21 AMGilead downgraded at Truist on cancer strategymsn.com - February 22 at 7:11 PMAnalysts Offer Insights on Healthcare Companies: Arcus Biosciences (RCUS), Ionis Pharmaceuticals (IONS) and Icon (ICLR)markets.businessinsider.com - February 22 at 2:10 PMArcus Biosciences, Inc. (NYSE:RCUS) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - February 22 at 2:10 PMArcus Biosciences: Trading At Large Discount To Recent Gilead Investmentseekingalpha.com - February 22 at 11:13 AMArcus Biosciences (NYSE:RCUS) Trading 12.1% Higher After Strong Earningsmarketbeat.com - February 22 at 10:23 AMArcus Biosciences' (RCUS) "Outperform" Rating Reaffirmed at Wedbushmarketbeat.com - February 22 at 8:51 AMArcus Biosciences GAAP EPS of -$1.08 misses by $0.06, revenue of $31M beats by $2.7Mmsn.com - February 21 at 7:52 PMArcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Updatefinance.yahoo.com - February 21 at 7:52 PMArcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Updatebusinesswire.com - February 21 at 4:05 PMRCUS Mar 2024 30.000 callfinance.yahoo.com - February 18 at 4:03 PMRCUS Mar 2024 20.000 putfinance.yahoo.com - February 18 at 4:03 PMRCUS Mar 2024 10.000 callca.finance.yahoo.com - February 17 at 8:01 PMRCUS Mar 2024 12.500 callca.finance.yahoo.com - February 17 at 9:59 AMDTIL Mar 2024 2.500 putfinance.yahoo.com - February 16 at 11:58 PMArcus Biosciences (NYSE:RCUS) Shares Gap Up to $15.81marketbeat.com - February 12 at 11:45 AMArcus Biosciences Announces New Employment Inducement Grantsbusinesswire.com - February 9 at 4:35 PMFY2023 Earnings Estimate for Arcus Biosciences, Inc. (NYSE:RCUS) Issued By Cantor Fitzgeraldmarketbeat.com - February 8 at 6:44 AMBarclays PLC Raises Position in Arcus Biosciences, Inc. (NYSE:RCUS)marketbeat.com - February 8 at 5:43 AMArcus Biosciences to Host Conference Call to Discuss Fourth-Quarter and Full-Year 2023 Financial Results and Pipeline Updatesfinance.yahoo.com - February 7 at 7:28 PM Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here Click here for the full story RCUS Media Mentions By Week RCUS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCUS News Sentiment▼1.340.49▲Average Medical News Sentiment RCUS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCUS Articles This Week▼33▲RCUS Articles Average Week Get Arcus Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for RCUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Zai Lab News Today Taro Pharmaceutical Industries News Today Kura Oncology News Today Agios Pharmaceuticals News Today Dynavax Technologies News Today Avadel Pharmaceuticals News Today Morphic News Today Edgewise Therapeutics News Today Ardelyx News Today NewAmsterdam Pharma News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:RCUS) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingBiden’s $374B Giveaway Into This SectorDTIThe “Perfect Storm” for GoldGold Safe ExchangeThe Next Nvidia?InvestorPlace1970’s computer coder issues shocking A.I. warningTradeSmithA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsUrgent alert: open this for a huge profit potentialTimothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arcus Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.